Cipla Ltd. — Regulatory Filings 2021

Jun 8, 2021

8[th] June, 2021

• (1) BSE Ltd (2) National Stock Exchange of India Ltd Listing Department Listing Department Phiroze Jeejeebhoy Towers, Exchange Plaza, 5[th] floor, Dalal Street, Plot no. C/1, G Block, Mumbai - 400 001 Bandra Kurla Complex, Bandra (East), Mumbai - 400 051

Scrip Code: 500087

Scrip Code: CIPLA

• (3) SOCIETE DE LA BOURSE DE LUXEMBOURG Societe Anonyme 35A Boulevard Joseph II, L-1840 Luxembourg

Sub: Disclosure of related party transactions for the half year ended 31[st] March, 2021

Dear Sir/Madam,

Pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith disclosure of related party transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 31[st] March, 2021.

This disclosure is also being uploaded on the website of the Company i.e. www.cipla.com.

This is for your information and record.

Thanking you,

Yours faithfully, For Cipla Limited

RAJENDRA Digitally signed by RAJENDRA CHOPRA CHOPRA Date: 2021.06.08 14:50:24 +05'30'

Rajendra Chopra Company Secretary

Prepared by: Pratiksha Mangaonkar

==> picture [595 x 94] intentionally omitted <==

Consolidated disclosure of related party transactions and balances for the half year ended 31[st] March, 2021

Information on related party transactions as required by Ind AS-24 - 'Related Party Disclosures' are given below:

List of related parties

A. Associate

Stempeutics Research Private Limited Avenue Therapeutics, Inc. Brandmed (Pty) Limited AMPSolar Power Systems Private Limited GoApptiv Private Limited (w.e.f. 27[th] July, 2020)

B. Key management personnel

Ms. Samina Hamied - Executive Vice Chairperson

Mr. Umang Vohra – Managing Director and Global Chief Executive Officer Mr. Kedar Upadhye - Global Chief Financial Officer

C. Non executive chairman and non executive vice chairman

Dr. Y. K. Hamied, Chairman

Mr. M. K. Hamied, Vice Chairman

D. Non executive directors

Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Dr. Peter Mugyenyi Mr. S. Radhakrishnan

E. Entities over which the company is able to exercise significant influence

Cipla Foundation

Chest Research Foundation (Formerly known as Hamied Foundation upto 14[th] October, 2019) Cipla Cancer and AIDS Foundation

F. Post-employment benefit trusts

Cipla Limited Employees Provident Fund Cipla Limited Employees Gratuity Fund Goldencross Pharma Limited Employees Group Gratuity Fund Meditab Specialities Limited Employees Comprehensive Gratuity Scheme Medispray Laboratories Private Limited Employees Comprehensive Gratuity Scheme Cipla Biotec Private Limited Employees Gratuity Fund Jay Precision Pharmaceuticals Employees Group Gratuity Trust Cipla Health Limited Employees Gratuity scheme Sitec Labs Private Limited Employees Group Gratuity Scheme

==> picture [463 x 178] intentionally omitted <==

----- Start of picture text -----

₹ in Crores
For the half year ended
Particulars
31 [st] March, 2021
A. Remuneration (including sitting fees)
Dr. Y.K. Hamied 1.03
Mr. M.K. Hamied 1.05
Ms. Samina Hamied 4.75
Mr. Umang Vohra 8.01
Mr. S. Radhakrishnan 1.11
Mr. Kedar Upadhye 2.49
Mr. Ashok Sinha 0.27
Mr. Adil Zainulbhai 0.27
Ms. Punita Lal 0.24
Ms. Naina Lal Kidwai 0.25
Dr. Peter Mugyenyi 0.36
19.83
----- End of picture text -----*

B. Contribution to provident fund and other fund Cipla Limited Employees Gratuity Fund Cipla Limited Employees Provident Fund Medispray Laboratories Private Limited Employees Comprehensive Gratuity Scheme C. Donations given Cipla Foundation D. Rent received Dr. Y.K. Hamied (₹ 10,020/-) E. Service Charges and reimbursement paid Stempeutics Research Private Limited GoApptiv Private Limited F. Investment in Preference Shares GoApptiv Private Limited G. Payable to key management personnel and non executive directors Dr. Y.K. Hamied Mr. M.K. Hamied Ms. Samina Hamied Mr. Umang Vohra Mr. S. Radhakrishnan Mr. Kedar Upadhye Mr. Ashok Sinha Mr. Adil Zainulbhai Ms. Punita Lal Ms. Naina Lal Kidwai Dr. Peter Mugyenyi * Expenses towards gratuity, compensated absences and premium paid for group health insurance has not information as a separate actuarial valuation/premium paid are not available.

6.70 19.69 0.63 27.02 - - 0.00 0.00 0.63 9.46 10.09 3.20 3.20 2.00 2.00 3.50 5.00 2.00 1.35 0.40 0.36 0.35 0.35 0.41 17.72 been considered in above

₹ in Crores For the half year ended 31[st] March, 2021

Particulars

H. Contribution payable to provident fund Cipla Employees Provident Fund I. Advances receivable from gratuity fund Sitec Labs Private Limited Employees Group Gratuity Scheme Goldencross Pharma Limited Employees Group Gratuity Fund Meditab Specialities Limited Employees Comprehensive Gratuity Scheme Medispray Laboratories Private Limited Employees Comprehensive Gratuity Scheme J. Contribution payable to gratuity fund Cipla Limited Employees Gratuity Fund Cipla Health Limited Employees Gratuity scheme K. Payable to associates GoApptiv Private Limited L. Payable towards acquisition of stake in associate Brandmed (Pty) Limited M. Electricity charges paid AMPSolar Power Systems Private Limited N. Purchase of goods Brandmed (Pty) Limited

11.02 11.02 1.11 0.04 0.01 0.12 1.28 4.26 0.95 4.26 0.29 0.29 2.47 2.47 2.42 2.42 4.99 4.99